text: Effective measures for secondary prevention of glycogen<unk>  disease type 1 (GSD type 1) include blood glucose (BG) monitoring, prevent overtreatment, growth tracking as well as several system wise recommendations including general medical care, gastrointestinal or nutritional, hepatic and hepatic transplantation, nephrology, hematology, cardiovascular, surgery/anesthesia, and gynecological/obstetrical recommendations.
option_0: Glycogen storage disease type I secondary prevention
option_1: Glycogen storage disease type II secondary prevention
option_2: Glycogen storage disease type III secondary prevention
option_3: Glycogen storage disease type II primary prevention
option_4: Glycogen storage disease type III primary prevention
option_5: Glycogen storage disease type I primary prevention
option_6: Glycogen storage disease type II medical therapy
option_7: Glycogen storage disease type I medical therapy